# CO2 (Carbon Dioxide) - Cerebral Oxygenation

> **NCT03338907** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 30 (actual)

## Conditions studied

- Hypoxia, Brain

## Interventions

- **DRUG:** Oxycarbon (5% CO2+ 95% O2)

## Key facts

- **NCT ID:** NCT03338907
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-25
- **Primary completion:** 2018-10-26
- **Final completion:** 2019-02-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03338907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03338907, "CO2 (Carbon Dioxide) - Cerebral Oxygenation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03338907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
